Bigul

Eris Lifesciences Ltd - 540596 - Board Meeting Intimation for Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended 31 December 2022.

Eris Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/01/2023 ,inter alia, to consider and approve unaudited financial results of the Company for the quarter ended 31 December 2022.
10-01-2023
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
04-01-2023
Bigul

Eris Lifesciences Ltd - 540596 - Closure of Trading Window

INTIMATION OF CLOSURE OF TRADING WINDOW
30-12-2022
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
20-12-2022
Bigul

Eris Lifesciences Ltd - 540596 - INTIMATION OF SUBMISSION OF APPLICATION FOR RECLASSIFICATION

Intimation of submission of application of promoter reclassification - Shah & Co.
18-11-2022
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
14-11-2022
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
09-11-2022
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
07-11-2022
Bigul

Eris Lifesciences Ltd - 540596 - DISCLOSURES OF RELATED PARTY TRANSACTIONS UNDER REGULATION 23(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED ('SEBI LISTING REGULATIONS')

DISCLOSURES OF RELATED PARTY TRANSACTIONS UNDER REGULATION 23(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED ('SEBI LISTING REGULATIONS')
04-11-2022
Bigul

Eris Lifesciences Ltd - 540596 - CORPORATE PRESENTATION

Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached corporate presentation made by the Company.
03-11-2022
Next Page
Close

Let's Open Free Demat Account